Vitalhub Corp. (TSE:VHI – Free Report) – Research analysts at Raymond James Financial cut their Q3 2025 earnings estimates for shares of Vitalhub in a note issued to investors on Thursday, June 19th. Raymond James Financial analyst M. Freeman now expects that the company will earn $0.00 per share for the quarter, down from their prior estimate of $0.05. Raymond James Financial has a “Outperform” rating and a $14.00 price objective on the stock. The consensus estimate for Vitalhub’s current full-year earnings is $0.23 per share. Raymond James Financial also issued estimates for Vitalhub’s Q4 2025 earnings at $0.03 EPS and FY2025 earnings at $0.10 EPS.
Several other research firms have also recently weighed in on VHI. National Bankshares set a C$14.00 price objective on Vitalhub and gave the stock an “outperform” rating in a research report on Tuesday, June 10th. TD Securities lifted their target price on Vitalhub from C$13.00 to C$14.00 and gave the stock a “buy” rating in a research note on Monday, March 31st. National Bank Financial upgraded shares of Vitalhub to a “strong-buy” rating in a research report on Monday, June 9th. Finally, Scotiabank raised their price objective on shares of Vitalhub from C$14.00 to C$14.50 and gave the stock an “outperform” rating in a report on Friday, June 20th. Six investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Buy” and an average target price of C$13.25.
Vitalhub Stock Down 0.7%
VHI stock opened at C$10.96 on Monday. The firm has a market cap of C$592.85 million, a PE ratio of 178.26, a P/E/G ratio of 1.18 and a beta of 1.26. The business has a 50 day moving average of C$10.64 and a 200-day moving average of C$10.61. Vitalhub has a 12-month low of C$6.74 and a 12-month high of C$12.34.
Insider Transactions at Vitalhub
In other Vitalhub news, Director Francis Nelson Shen purchased 25,000 shares of the stock in a transaction dated Friday, May 16th. The shares were bought at an average price of C$10.23 per share, with a total value of C$255,750.00. 18.57% of the stock is owned by corporate insiders.
Vitalhub Company Profile
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Further Reading
- Five stocks we like better than Vitalhub
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- 3 Hot Trades for Insiders, But Are They Good Buys for Investors?
- The Risks of Owning Bonds
- Why Qualcomm’s Latest Price Target Can’t Be Ignored
- Using the MarketBeat Dividend Yield Calculator
- Analyst Sees Meta Hitting $800: What May Lead Shares to New Highs
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.